ArticleDrug and alcohol review2026
Evaluating the Pattern of Kava (Piper methysticum) Consumption in Australia by Wastewater-Based Epidemiology.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionKava (Piper methysticum) is a plant native to the Pacific Islands, used in the preparation of a beverage consumed during ceremonies. The plant has gained popularity in other countries as a supplement for the treatment of anxiety and insomnia. Nevertheless, products containing P. methysticum were associated with liver damage, which led to the kava ban in several jurisdictions across the world, including Australia. However, in 2019, the Australian government started relaxing import restrictions as part of the kava pilot. It is therefore of interest to establish a baseline of kava consumption on a national population scale, serving as a reference point for understanding the long-term effect of this policy change.
methodsWastewater analysis of kavalactones and metabolites was employed to establish a baseline measurement of use in Australia. Influent samples were collected from 54 wastewater treatment plants from December 2023 to December 2024. Liquid-liquid extraction was used for sample preparation, followed by liquid chromatography-tandem mass spectrometry analysis.
resultsEight chemical markers were detected in wastewater collected from all participating treatment plants. The highest excreted loads were measured in regional Western Australia and the capital cities of New South Wales and the Northern Territory. DISCUSSION AND
conclusionsThe use of kava and P. methysticum containing products was on average higher in regional areas compared to capital cities, and elevated at the weekend, suggesting recreational use. Wastewater analysis can provide specific insights into the use of kava and P. methysticum containing products and is implemented as part of routine drug epidemiology programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.